Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Residual DNA Testing Market Size, Share, Trends, and Forecast, 2026-2033 | Biologics and Gene Therapy Growth Fuels 6.8% CAGR to USD 525.3 Million

globenewswire.com
TMO Thermo Fisher Scientific is listed as a company featured in the competitive landscape of the residual DNA testing market report, indicating its involvement in this sector. The article does not provide specific sentiment towards the company's performance. MRK Merck KGaA is mentioned as a featured company in the competitive landscape of the residual DNA testing market. The article does not offer specific sentiment or performance details for the company. CRL Charles River Laboratories is listed as a featured company within the competitive landscape of the residual DNA testing market. The article does not provide specific sentiment or performance analysis for the company. BIO Bio-Rad Laboratories, Inc. is mentioned as a featured company in the competitive landscape of the residual DNA testing market. The article does not offer specific sentiment or performance details for the company. QGEN QIAGEN N.V. is listed as a featured company in the competitive landscape of the residual DNA testing market. The article does not provide specific sentiment or performance analysis for the company. MRVI Maravai LifeSciences is listed as a featured company in the competitive landscape of the residual DNA testing market. The article does not provide specific sentiment or performance analysis for the company.

Global Residual DNA Testing Market Size, Share, Trends, and Forecast, 2026-2033 | Biologics and Gene Therapy Growth Fuels 6.8% CAGR to USD 525.3 Million Dublin, Sept. 29, 2026 (GLOBE NEWSWIRE) -- "Residual DNA Testing Market Size, Share & Trends Analysis Report by Product & Service, Test Type, Technology by Application, End-User, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global residual DNA testing market was valued at an estimated USD 309.3 million in 2025 and is projected to reach USD 525.3 million by 2033. The market is expected to expand at a compound annual growth rate of 6.8% from 2026 to 2033, supported by increasingly stringent regulatory requirements, expanding biologics manufacturing, accelerating cell and gene therapy development, and continued advances in sensitive DNA detection technologies.

Residual DNA testing is becoming an increasingly important component of biopharmaceutical quality control and product safety programs. Pharmaceutical and biotechnology companies are strengthening analytical testing capabilities as regulators increase scrutiny of biological products manufactured using cell substrates. Growing pipelines for monoclonal antibodies, vaccines, and advanced therapies are also generating demand for accurate, reproducible, and scalable testing solutions.

Technological innovation is expected to influence market development throughout the forecast period. PCR remains a major testing platform, while threshold assays, DNA probe hybridization, and Next-Generation Sequencing support a wider range of analytical requirements. Improvements in assay sensitivity, workflow efficiency, automation, and data quality are helping manufacturers address complex testing needs across raw materials, bulk production, and final product evaluation.

Global Residual DNA Testing Market Report Segmentation

The report analyzes revenue growth and key market trends across product and service categories, test types, technologies, applications, end-users, and geographic markets from 2021 to 2033.

Product & Service Outlook - Revenue, USD Million, 2021-2033

Demand across these categories is being supported by laboratory expansion, recurring assay requirements, regulatory compliance programs, and increased outsourcing of specialized analytical testing.

Test Type Outlook - Revenue, USD Million, 2021-2033

Technology Outlook - Revenue, USD Million, 2021-2033

Application Outlook - Revenue, USD Million, 2021-2033

Cell & gene therapy is positioned as an important growth area as clinical pipelines mature and more advanced therapies move toward commercial manufacturing. Monoclonal antibody and vaccine production will continue to create testing opportunities due to established quality requirements and sustained biopharmaceutical investment.

End-user Outlook - Revenue, USD Million, 2021-2033

Pharmaceutical and biotechnology companies represent a central customer group, while CROs & CMOs are benefiting from greater demand for outsourced development, manufacturing, and quality testing. Academic and research institutes also contribute to market growth through translational research and emerging therapeutic programs.

Regional Outlook - Revenue, USD Million, 2021-2033

North America and Europe remain significant markets due to established biopharmaceutical industries, rigorous regulatory frameworks, and strong research infrastructure. Asia Pacific presents expanding opportunities as biologics manufacturing capacity increases across China, Japan, India, South Korea, and other regional economies. Latin America and MEA are also gaining relevance through healthcare investment, local production initiatives, and broader access to advanced analytical services.

Strategic Value of the Report

The report provides decision-makers with a structured assessment of the global residual DNA testing market, including revenue forecasts, competitive insights, regional opportunities, and technology trends. These findings can support informed strategic planning among testing providers, instrument manufacturers, consumables suppliers, pharmaceutical companies, biotechnology developers, research organizations, CROs, and CMOs.

Key Attributes:

Key Topics Covered:

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope

1.2. Market Definitions

1.2.1. Product & Service Segment

1.2.2. Technology Segment

1.2.3. Test Type Segment

1.2.4. Application Segment

1.2.5. End user Segment

1.3. Information analysis

1.3.1. Market formulation & data visualization

1.4. Data validation & publishing

1.5. Information Procurement

1.5.1. Primary Research

1.6. Information or Data Analysis

1.7. Market Formulation & Validation

1.8. Market Model

1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

Chapter 3. Residual DNA Testing Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent market outlook

3.1.2. Related/ancillary market outlook.

3.2. Market Dynamics

3.2.1. Market driver analysis

3.2.2. Market restraint analysis

3.2.3. Market opportunity analysis

3.2.4. Market challenge analysis

3.3. Case Study Insights

3.4. Residual DNA Testing Market Analysis Tools

3.4.1. Industry Analysis - Porter's

3.4.2. PESTEL Analysis

Chapter 4. Residual DNA Testing Market: Product & Service Estimates & Trend Analysis

4.1. Segment Dashboard

4.2. Global Residual DNA Testing Market Product & Service Movement Analysis

4.3. Global Residual DNA Testing Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)

4.4. Instruments

4.4.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)

4.5. Consumables

4.5.1. Consumables market estimates and forecasts 2021 to 2033 (USD Million)

4.6. Services

4.6.1. Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Residual DNA Testing Market: Test Type Estimates & Trend Analysis

5.1. Segment Dashboard

5.2. Global Residual DNA Testing Market Test Type Movement Analysis

5.3. Global Residual DNA Testing Materials Market Size & Trend Analysis, by Test Type, 2021 to 2033 (USD Million)

5.4. Raw Material Testing

5.4.1. Raw material testing market estimates and forecasts 2021 to 2033 (USD Million)

5.5. Bulk Testing

5.5.1. Bulk testing market estimates and forecasts 2021 to 2033 (USD Million)

5.6. Final Product Testing

5.6.1. Final product testing market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Residual DNA Testing Market: Technology Estimates & Trend Analysis

6.1. Segment Dashboard

6.2. Global Residual DNA Testing Market Technology Movement Analysis

6.3. Global Residual DNA Testing Materials Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)

6.4. PCR

6.4.1. PCR market estimates and forecasts 2021 to 2033 (USD Million)

6.5. Threshold Assays

6.5.1. Threshold assays market estimates and forecasts 2021 to 2033 (USD Million)

6.6. DNA Probe Hybridization

6.6.1. DNA probe hybridization market estimates and forecasts 2021 to 2033 (USD Million)

6.7. Next-Generation Sequencing

6.7.1. Next-generation sequencing market estimates and forecasts 2021 to 2033 (USD Million)

6.8. Others

6.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Residual DNA Testing Market: Application Estimates & Trend Analysis

7.1. Segment Dashboard

7.2. Global Residual DNA Testing Market Application Movement Analysis

7.3. Global Residual DNA Testing Materials Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)

7.4. Monoclonal Antibodies

7.4.1. Monoclonal antibodies market estimates and forecasts 2021 to 2033 (USD Million)

7.5. Vaccines

7.5.1. Vaccines market estimates and forecasts 2021 to 2033 (USD Million)

7.6. Cell & Gene Therapy

7.6.1. Cell & gene therapy market estimates and forecasts 2021 to 2033 (USD Million)

7.7. Others

7.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Residual DNA Testing Market: End user Estimates & Trend Analysis

8.1. Segment Dashboard

8.2. Global Residual DNA Testing Market End user Movement Analysis

8.3. Global Residual DNA Testing Market Size & Trend Analysis, by End user, 2021 to 2033 (USD Million)

8.4. Pharmaceutical & Biotechnology Companies

8.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)

8.5. CROs & CMOs

8.5.1. CROs & CMOs market estimates and forecasts 2021 to 2033 (USD Million)

8.6. Academic & Research Institutes

8.6.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Residual DNA Testing Market: Regional Estimates & Trend Analysis

9.1. Regional Market Share Analysis, 2025 & 2033

9.2. Regional Market Dashboard

9.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:

9.4. North America

9.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)

9.4.2. U.S.

9.4.3. Canada

9.4.4. Mexico

9.5. Europe

9.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

9.5.2. UK

9.5.3. Germany

9.5.4. France

9.5.5. Italy

9.5.6. Spain

9.5.7. Norway

9.5.8. Sweden

9.5.9. Denmark

9.6. Asia-Pacific

9.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)

9.6.2. Japan

9.6.3. China

9.6.4. India

9.6.5. Australia

9.6.6. South Korea

9.6.7. Thailand

9.7. Latin America

9.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

9.7.2. Brazil

9.7.3. Argentina

9.8. MEA

9.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)

9.8.2. South Africa

9.8.3. Saudi Arabia

9.8.4. UAE

9.8.5. Kuwait

Chapter 10. Competitive Landscape

10.1. Company/Competition Categorization

10.2. Strategy Mapping

10.3. Company Market Position Analysis, 2025

10.4. Company Profiles/Listing

10.4.1. Thermo Fisher Scientific, Inc.

10.4.2. Merck KGaA

10.4.3. Charles River Laboratories

10.4.4. Eurofins Scientific

10.4.5. Bio-Rad Laboratories, Inc.

10.4.6. QIAGEN N.V.

10.4.7. F. Hoffmann-La Roche Ltd.

10.4.8. Maravai LifeSciences

10.4.9. FUJIFILM Corporation

10.4.10. Sartorius AG

List of Tables [152]

List of Figures [90]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/2q5ky2

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.